Literature DB >> 26511991

The challenging diagnosis of haemophagocytic lymphohistiocytosis in an HIV-infected patient.

Luísa Azevedo1, Rita Gerivaz2, Joana Simões1, Isabel Germano1.   

Abstract

The differential diagnosis of febrile pancytopenia in the setting of HIV infection can be challenging. The authors report a case of a 34-year-old man with advanced HIV infection (TCD4=8 cells/mm(3)) and a 2-month history of fever, weight loss and asthaenia. On observation, he was emaciated, hyperthermic and pale, with a haemorrhagic oropharyngeal lesion, penile violaceous lesions and palpable hepatosplenomegaly. Blood tests showed pancytopenia, hyperferritinaemia and hypertriglyceridaemia; imaging confirmed hepatosplenomegaly and a bone marrow biopsy revealed HIV-associated dyshematopoiesis. Biopsy of the aforementioned lesions displayed Kaposi sarcoma; extensive investigation was negative for other opportunistic infections or lymphoproliferative disease. Despite only a posteriori histological documentation, haemophagocytic lymphohistiocytosis (HLH) was considered; chemotherapy and antiretrovirals were started, with excellent response. There was, however, disease relapse requiring an intensification course, with sustained remission at 18-month follow-up. HLH is a rare disease, with non-specific presentation, requiring a high index of suspicion since treatment delay can be fatal. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26511991      PMCID: PMC4636697          DOI: 10.1136/bcr-2015-211817

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 2.  Haemophagocytic syndrome in patients infected with the human immunodeficiency virus: nine cases and a review.

Authors:  G Grateau; C Bachmeyer; P Blanche; M Jouanne; M Tulliez; C Galland; D Sicard; D Séréni
Journal:  J Infect       Date:  1997-05       Impact factor: 6.072

Review 3.  Haemophagocytic syndrome and HIV.

Authors:  Tomas Doyle; Sanjay Bhagani; Kate Cwynarski
Journal:  Curr Opin Infect Dis       Date:  2009-02       Impact factor: 4.915

Review 4.  The haematological features of HIV infection.

Authors:  B J Bain
Journal:  Br J Haematol       Date:  1997-10       Impact factor: 6.998

5.  Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies.

Authors:  G W Niedt; R A Schinella
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

Review 6.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  G E Janka
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

Review 7.  [Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients].

Authors:  L Sailler; E Duchayne; B Marchou; P Brousset; J Pris; P Massip; J Corberand; P Arlet
Journal:  Rev Med Interne       Date:  1997       Impact factor: 0.728

8.  Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis.

Authors:  Laurence Fardet; Olivier Lambotte; Jean-Luc Meynard; Wassim Kamouh; Lionel Galicier; Christophe Marzac; Adrienne de Labarthe; Jean Cabane; Céleste Lebbe; Paul Coppo; Jean-Michel Molina; Valérie Martinez
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

9.  Reactive hemophagocytosis associated with the initiation of highly active antiretroviral therapy (HAART) in a patient with AIDS.

Authors:  David B Huang; Jashin J Wu; Richard J Hamill
Journal:  Scand J Infect Dis       Date:  2004

10.  Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis.

Authors:  Carl E Allen; Xiaoying Yu; Claudia A Kozinetz; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2008-06       Impact factor: 3.167

View more
  7 in total

1.  Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV/AIDS.

Authors:  Anthony J Ocon; Birju D Bhatt; Cynthia Miller; Ruben A Peredo
Journal:  BMJ Case Rep       Date:  2017-10-04

2.  Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis.

Authors:  Beatrice Clare Cockbain; Borja Mora Peris; Aula Abbara; Chun Wah So; Graham Cooke
Journal:  BMJ Case Rep       Date:  2019-02-11

Review 3.  Hemophagocytic Lymphohistiocytosis Secondary to Unknown Underlying Hodgkin Lymphoma Presenting with a Cholestatic Pattern of Liver Injury.

Authors:  A L Booth; P Osehobo; D Rodgers-Soriano; A Lalarukh; M A Eltorky; H L Stevenson
Journal:  Case Rep Gastroenterol       Date:  2018-04-24

4.  Clinical characteristics of liver failure with hemophagocytic lymphohistiocytosis.

Authors:  Jinling Dong; Fang Xie; Lin Jia; Juan Li; Zhongjie Hu; Yueke Zhu; Hongwei Yu; Yujuan Zhao; Qinwei Yao; Qinghua Meng
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

5.  A Rare Case of HHV-8 Associated Hemophagocytic Lymphohistiocytosis in a Stable HIV Patient.

Authors:  Nonso Osakwe; Diane Johnson; Natalie Klein; Dalia Abdel Azim
Journal:  Case Rep Infect Dis       Date:  2019-04-28

6.  Hemophagocytic Lymphohistiocytosis Associated With Parvovirus B19 in a Patient With Acquired Immunodeficiency Syndrome.

Authors:  Precious Macauley; Mohammad Abu-Hishmeh; Carissa Dumancas; Vijay Alexander-Rajan; Fernando Piedra-Chavez; Khaled Nada; Imnett Habtes; Andrea Popescu; Aleksandra Mamorska-Dyga
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

Review 7.  A Review of Hemophagocytic Lymphohistiocytosis in Patients With HIV.

Authors:  Hussam Tabaja; Amjad Kanj; Said El Zein; Isin Yagmur Comba; Omar Chehab; Maryam Mahmood
Journal:  Open Forum Infect Dis       Date:  2022-02-11       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.